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Objective. To evaluate the quality of prenatal results in all cases of termination of pregnancy (TOP) due to fetal abnormalities in a
tertiary prenatal diagnosis center. Material and Methods. Retrospective analysis of the 385 TOP performed on our department
due to fetal abnormalities between January 1, 2000, and December 31, 2007. We compared all data for agreement between
the ultrasound, genetic, and postmortem ﬁndings, regarding the abnormalities identiﬁed in the etiological diagnosis and its
prognosis. Results. Chromosome abnormalities were the most common indication for TOP (39%), followed by abnormalities
of CNS (20%), monogenic disorders (11%), sequences (9.6%), polimalformative syndromes (5.2%), and isolated congenital heart
diseases (4%). Total agreement was 21%. Further abnormalities were identiﬁed in 79%. The data collected after TOP changed the
etiologic diagnosis in 21% but the prognosis was changed in only one fetus. Discussion. This study corroborates the necessity of
a multidisciplinary team in prenatal diagnosis centers. Their work remarkably improves the genetic counseling and represents an
important aspect in quality control of the information given to a couple previously to a TOP.
1.Introduction
Fetal abnormalities are the major cause of perinatal death
and contribute to the increase of the morbidity after birth
[1, 2]. In this context prenatal ultrasound has become the
main method for detecting fetal anomalies [3, 4].
Accurate prenatal diagnosis of fetal anomalies is essential
to the parental decision and the assessment of the recurrence
risk. The genetic evaluation and fetal pathology examination
after the TOP allow to improve the ability to achieve a
diagnosis, to reﬁne the prognosis, and to enhance the genetic
counseling, as well as to audit the quality and accuracy of
prenatal ultrasound [5–8].
The main goal of this study was to review the prenatal
diagnosis experience in cases of TOP for fetal abnormalities
i no u rd e p a r t m e n to v e rap e r i o do fe i g h ty e a r s .W eh a v e
collected and compared the prenatal clinical ﬁndings with
the genetic evaluation and the postmortem results. This
was done in order to assess the contribution of genetic
evaluationandautopsyinimprovingthediagnosticskillsand
the couple’s counseling.
2.MaterialandMethods
We audited 385 cases of TOP performed because of fetal
abnormalities between January 1, 2000, and December 31,
2007, at the Prenatal Diagnosis Center of Maternidade
Bissaya Barreto, Centro Hospitalar de Coimbra. All cases
had data regarding the results of prenatal ultrasound and
laboratory evaluation, observation of the fetus after TOP by
clinical geneticist, who could request further exams (such as
fetalX-rayscytogenetic,molecular,orenzymatictestsoffetal
samples) and fetal pathology.
All cases with fetal malformations were evaluated for the
same team of sonographers, trained in fetal medicine. The
ultrasound equipment used was a Toshiba Xario that has
transabdominal and transvaginal transducers with frequen-
cies ranging from 3.5 to 5MHz.2 ISRN Obstetrics and Gynecology
Cytogenetic (karyotype and FISH analysis for speciﬁc
probes) and molecular tests were performed when indicated
after amniocentesis or chorionic villus sampling biopsy. In
many cases with cytogenetic abnormalities, invasive prenatal
diagnosis was carried out due to advanced maternal age (age
greater or equal to 35 years at the estimated due date).
The postmortem studies were performed after informed
consent and were done according to protocols described
by Keeling and adapted by Brand˜ ao and Laurini [9, 10].
The ultrasound and genetic ﬁndings were available to the
pathologists before the postmortem evaluation.
All TOPs performed at our department were con-
secutively recorded. We reviewed the TOP due to fetal
abnormalities and gathered all the data from the sono-
graphic, genetic (fetal observation and laboratorial tests),
and postmortem records. The results were compared for the
presence or absence of agreement at the TOP and the ﬁnal
genetic counseling. Total agreement was considered when no
relevant ﬁndings (regarding abnormalities that threaten life,
require surgery or medical treatment, impair signiﬁcantly
organic function or appearance or were relevant to the
etiological diagnosis) were added to ultrasound results after
geneticevaluationorautopsy.Disagreementwasstatedwhen
relevant ﬁndings were identiﬁed at the genetic and/or fetal
pathology evaluation.
Whenever disagreement was identiﬁed, we also evaluated
whether it led to a change in the diagnosis and/or prognosis.
All the information was used to improve the genetic
counseling of these couples.
3. Results
Atotalof385caseswereincludedinthisstudy.Chromosome
abnormalities were the most common indication for TOP
(149/385; 39%). Numerical chromosome abnormalities were
diagnosed in 122 fetuses in which trisomy 21 was the
leading cause (67 cases) followed by trisomy 18 (21 cases),
trisomy 13 (16 cases), X monosomy with hydrops (12
cases), and mosaics for other numerical abnormalities (6
cases). Euploidies occurred in 5 cases (4 triploidies and
1 tetraploidy). Structural unbalanced abnormalities were
presented in 22 cases. In 52% (77/149) of the chromosome
abnormalities,theinvasiveprenataldiagnosiswasperformed
due to advanced maternal age.
Central nervous system malformations were diagnosed
in 77 cases (20%). Neural tube defects (anencephaly,
myelomeningocele and encephalocele) were found in 59
cases (15%). A central nervous tumor was diagnosed in two
fetuses. One was an embryonic tumor and the other a giant
dermoid cyst.
Monogenic disorders were responsible for 11% of TOP
(44/385 cases), which could be divided in two groups:
those with previous familial history and those in which the
fetus was the index case. On the ﬁrst group, the molecular
diagnosis was oﬀered to 13 cases (3.4%). The analysis
of an autosomal recessive disease was the most common
request. In one couple with a previous child with Walker-
Warburg syndrome, the diagnosis was exclusively based on
ultrasound ﬁndings, because no mutation was found on the
index case. Thirty-one cases (8%) belonged to the second
group. On these disorders and after the fetal observation
and postmortem ﬁndings, the genetic assessment allowed an
accurate diagnosis in 84% (26/31 cases) of the cases. Their
work was crucial in 16 of these cases, the pathological study
byitselfinﬁvecasesofthemandacollaborationofbothareas
in other ﬁve cases.
Sequences (deﬁned as a pattern of developmental
anomalies consequent upon a primary defect, often with
heterogeneous etiology) were presented in 37 cases (9.6%).
The most common sequence was oligohydramnios sequence
(Potter syndrome) in 17 cases. Amnion rupture sequence
(amniotic bands) was diagnosed in six cases and early
urethral obstruction sequence in also six cases; laterality
sequences with left isomerism (polysplenia syndrome) and
right isomerism (Ivemark syndrome) were identiﬁed in two
cases. Other sequences were identiﬁed in six cases.
Twenty cases (5.2%) had a recognized nonmonogenic
nonchromosomal syndrome. In all of these cases, no speciﬁc
etiologic diagnosis could be found; however the observation
of the fetus by the geneticist and the autopsy added essential
information for the genetic counseling.
Sixteen cases (4%) had the prenatal diagnosis of an
isolated congenital heart disease. The postmortem studies
did not change the severity of these anomalies but were able
to better characterize it in 11 cases.
In ﬁve cases of nonimmune hydrops fetalis no etio-
logic diagnosis was established, even after assessment of
structural abnormalities of fetal heart, chromosome abnor-
malities, hemoglobinopathies, infections, and metabolic
diseases (such as mucolipidosis I and II, galactosialidosis,
mucopolysaccharidosis type I, IV, and VII, Gaucher disease
type 2, gangliosidosis, Niemann-Pick disease type IA and C,
multiple sulfatase deﬁciency, and sialic acid storage disease).
Infections were the cause of fetal abnormalities in ﬁve
cases, cytomegalovirus in four cases, and parvovirus B19 in
one case, as fetal hydrops.
Teratogens were identiﬁed in ﬁve cases. The use of miso-
prostol was the most common cause, found in 4 cases, and
there was one warfarin embryopathy.
Other diagnoses were identiﬁed in 24 cases, such
as acardiac fetus, umbilical cord abnormalities, placental
abnormalities, cervical lymphangioma, severe decreased/
absent fetal movement, and structural anomalies (bilateral
micropthalmia, phocomelia of upper limbs, and spinal
anomalies).
The anomalies are summarized in Table 1.
We have compared all the results from the obstetric,
genetic, and fetal pathology evaluations for the presence or
absence of agreement. Total agreement on the three areas
was found in 165 cases (42%). The central nervous system
anomalies were the main group with total agreement—
70% (54/77 cases)—speciﬁcally the neural tube defects 81%
(48/59 cases). Concordance in oligohydramnios sequence
was 35% (6/17 cases). Prenatal diagnosis of familial syn-
dromes had a total agreement in 84% (11/13 cases) of the
cases. On the chromosome abnormality group we had a total
of concordance of only 37%. All data were concordant inISRN Obstetrics and Gynecology 3
Table 1: Anomalies found in 385 cases after TOP.
Anomalies Number of
cases
Chromosomeabnormalities 149
Numerical 122
Trisomy 13 16
Trisomy 18 21
Trisomy 21 67
Monosomy X 12
Other 6
Structural unbalanced 22
Euploidies 5
Nervous system anomalies 77
Neural tube defects 59
Other 18
Monogenic disorders 44
Familial syndromes 13
Hemophilia A 3
X- fragile syndrome 2
Muscular spinal atrophy 1
Beta-thalassemia 1
Sickle cell anemia 1
Mucopolysaccharidosis type I 1
Gangliosidosis type I 1
Metachromatic leucodystrophy 1
Walker-Warburg syndrome 1
Familial amyloidotic polyneuropathy 1
Diagnosis of index case 31
Frontonasal dysplasia 3
Fryns syndrome 3
Meckel-Gruber syndrome 2
Multiple pterygium syndrome 2
Roberts syndrome 2
Bardet-Biedl syndrome 1
Thanatophoric dysplasia 1
Diastrophic dysplasia 1
Apert syndrome 1
Osteogenesis imperfecta type IIA 1
Tetraamelia with pulmonary agenesis 1
Bartsocas-Papas syndrome 1
Mucopolysaccharidosis type VII 1
Pfeiﬀer syndrome 1
Proteus syndrome 1
Atelosteogenesis type I 1
X-linked hydrocephalus 1
Solitary median maxillary central incisor syndrome 1
Other 6
Sequences 37
Oligohydramnios 17
Amnion rupture 6
Table 1: Continued.
Anomalies Number of
cases
Early urethral obstruction 6
Laterality sequences 2
Other 6
Polymalformative syndrome 20
Isolatedcongenital heart disease 16
Nonimmune hydrops 5
Infections 5
CMV 4
Parvovirus B19 1
Teratogen 5
Misoprostol 4
Warfarin 1
Other diagnoses 24
38% of the prenatal diagnoses for advanced maternal age
(29/77 cases).
Total concordance between obstetric data and genetic
observation and/or laboratory analysis was present in 111
cases(29%).Totalconcordancebetweengeneticﬁndingsand
autopsy results was present in 116 cases (30%). In 100 cases
(26%) there was total agreement between obstetric data and
fetal pathology evaluation.
Etiological diagnoses were changed or established after
the genetic and/or autopsy observations in 80 cases (21%).
After the genetic assessment (laboratorial results and fetal
observation) the etiological diagnosis was changed in 49%
(39/80 cases) of the cases. The postmortem results con-
tributed to a modiﬁcation of the diagnosis in 31% (25/80
cases) of the cases, and the identiﬁcation of fetal infection
in amniotic ﬂuid changed the diagnosis in 6% (5/80 cases).
The association between the autopsy ﬁndings and the data
fromthegeneticevaluationallowedtoidentifytheetiological
diagnosis or to change it in 14% of the cases (11/80 cases).
There was only one case in which the prenatal prognosis
was changed: in a twin pregnancy the diagnosis of one fetus
with structural abnormalities and the other with hydrops
being not conﬁrmed in the latter.
4. Discussion
In the last years, several studies tried to correlate the prenatal
diagnosis with the results provided by fetopathogical and
genetics evaluation and to compare the impact of the
new information to ﬁnal diagnosis, prognosis, and genetic
counseling.
In our study, chromosome abnormalities were the most
common diagnosis, representing 39% of cases. Advanced
maternal age was the major reason of its realization (52%).
Central nervous system anomalies (20%) and genetic syn-
dromes (11%) were the most frequent diagnosis after chro-
mosome abnormalities. Nonmonogenic nonchromosomal
polimalformative syndromes without speciﬁc etiology were4 ISRN Obstetrics and Gynecology
Table 2: Comparison of previous studies regarding total agreement and disagreement.
N◦ of cases Total agreement Total disagreement
Phadke and Gupta [11] 91 72.5% 2,2% (2/91)
Ramalho et al. [8] 76 61.1% 0
Kaasen et al. [4] 228 58.4% —
Kaiser et al. [12] 121 49% 2.4% (3/121)
Boyd et al. [7] 309 55% —
Sankar and Phadke [2] 206 59% 1% (2/206)
Our study 385 42% 0.2% (1/385)
presented in 5.2% of cases. In this group the genetic and
autopsy evaluations provided data that improved signif-
icantly the genetic counseling. Isolated congenital heart
disease was found only in 4% and congenital infections in
1% of the cases.
Vaknin et al. found that chromosome abnormalities were
themostcommoncauseofTOPin32%ofthecases,followed
by central nervous system in 27%, genetic syndromes in 5%,
and (22 cases) fetal infection of the cases in 8% [1]. Amini et
al. referred to 13.7% of chromosome abnormalities, 34.8%
of central nervous system anomalies, and 3.7% of isolated
congenital heart disease [13]. Boyd et al. f o u n da na b n o r m a l
karyotype in 46%, central nervous system abnormalities in
21%, monogenic disease in 8%, and isolated heart defect in
3% of the cases [7].
These studies and ours allow us to suggest a fairly
constant prevalence of central nervous system anomalies
and isolated congenital heart disease. There is a signiﬁcant
diﬀerence between the prevalence of genetic syndromes;
in our opinion this value is dependent on the extent of
the etiological investigation performed. There is a wide
diﬀerence in the prevalence of chromosome abnormalities,
w h i c hw er e l a t et od i ﬀerences in the design of each study.
Genetic evaluation, laboratory tests, and fetus observa-
tion by a clinical geneticist are a reality in our department
and proved to bring out valuable information. This was
shown mainly in precise the diagnosis in many situations
(49% of the cases in our study).
F e t a lp o s t m o r t e ms t u d i e sw e r en o ta l w a y sp e r f o r m e di n
other series. Boyd et al. showed that autopsy rates fell from
84% to 67% in 2000 [7]. Vaknin et al. had only 11% (52/462
cases) of cases submitted to fetopathological studies [1], and
inHungarystudyperformedbyKaiseretal.60%ofcaseshad
autopsy studies [12].
In our study, the importance of fetal pathology can
be seen when we analyze its weight in the alteration of
diagnosis by itself (31%) and in addition with the genetic
evaluation (14%). So the collaboration of a clinical geneticist
and a fetal pathologist in a prenatal diagnosis team in all
tertiary centers is essential. Their participation improved the
diagnostic skills in 45% of cases, in our department. This can
be also supported by the study of Phadke and Gupta They
found in their study that support from dysmorphologists
and geneticists in fetal evaluation changed or improved the
diagnosis in 33% of cases (13) and that is plays a crucial role
in speciﬁc etiologic diagnosis and genetic counseling [11].
Full agreement between all data (ultrasound, genetics,
and postmortem results) was obtained in 42% of cases
in contrast with other studies. Phadke and Gupta referred
to 72.5% of total concordance, Ramalho et al. 61.1%,
Kaasen et al. 40%, Kaiser et al. 49%, and Boyd et al. 55%
[4, 7, 8, 11, 12].
This discrepancy in the data can be attributed to the
methodology used to comparison. In our study we consid-
ered all relevant data obtained by observation of the fetus by
geneticist, in addition to the results of fetopathology, as able
tochangeorimprovetheetiologicdiagnosis.Inthesestudies,
except in that of Phadke et al., routine genetic evaluation
isolated was not referred to as a source of information to
diagnosis.
In only one situation the data changed the prognosis.
Kaiser et al. referred to 2.4% of cases, where indication to
TOP could not be supported after fetopathological results,
Sankar and Phadke had 2 cases with total disagreement in
206 cases analyzed, and Phadke and Gupta also had 2 cases
in 91examineted [2, 11, 12]. The data are summarized in
Table 2.
The diagnostic accuracy was improved in 80 cases (21%)
which corroborate the need of a multidisciplinary team in
prenatal centers, as already noted by other authors [2, 3, 6,
11–13].
In conclusion, our study in concordance with others
showed that when fetal anomalies have been detected by
ultrasound, the speciﬁc diagnosis can be made or reﬁned
with association of genetic evaluation and autopsy studies.
Altogether they aﬀect favorably the genetic counseling and
represent an important aspect to control the quality of
information given to a couple previously to a TOP.
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